Target intelligence / Profile preview

T cell receptor alpha variable 9-1 (TRAV9-1)

Target
TRAV9-1
Molecular classification
Receptor, Immunoglobulin superfamily, Non-catalytic tyrosine-phosphoryted receptor (NTR), Variable region of T cell receptor alpha chain
01

Overview

T cell receptor alpha variable 9-1 (TRAV9-1) is a protein-coding gene segment that encodes the variable region (V region) of the alpha chain of the **T cell receptor (TCR)** complex[1][2]. This segment participates in **antigen recognition** as part of the highly variable alpha chain expressed by T lymphocytes. The alpha-beta TCR is essential for adaptive immunity; it recognizes peptides presented by major histocompatibility complex (MHC) molecules on antigen presenting cells, triggering T cell activation and downstream signaling pathways involved in immune responses[1][3]. TRAV9-1 is one of many V segments that, through somatic recombination during T cell development, generate the diversity of antigen recognition seen in T cell repertoires[1][3]. Variability at this segment contributes to the specificity of individual T cells, but by itself does not define a therapeutic target, as it is *one of many possible variable region gene segments*; typically, therapeutic targeting involves entire TCRs (such as TCR-engineered T cell therapies) or the complex as a whole, rather than any specific V gene segment[1][3].

Other names
T cell receptor alpha variable 9-1TRAV9-1TCRAV9S1TRAV91
02

Biological functions

Antigen recognitionSignal transductionImmune response
03

Disease associations

Other (general immune defense; not directly linked to a single disease category)

Beyond the preview

Go deeper on T cell receptor alpha variable 9-1 (TRAV9-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 9-1 (TRAV9-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call